The Blue Jet Healthcare IPO price has been fixed between ₹329 – ₹346. The minimum investment required to Participate in the Blue Jet IPO by a retail investor is ₹14,878 at (₹346 per share) with a minimum lot of 43 Shares. Blue Jet Healthcare IPO opened on 25th October Wednesday and will close on Friday 27th October.
The Total Issue size is 24,285,160 shares of ₹2 (aggregating up to ₹840.27 Cr) , while the shareholding per issue 173,465,425 & the shareholding post issue is 173,465,425.
Allotment Date of Blue Jet Healthcare IPO
The Allotment of Blue Jet Healthcare IPO will be finalized on 1st November (Wednesday). The refunds for the same will be initiated on the 1st of November. The Blue Jet shares will be credited on 3rd of November while the Blue Jet IPO will list on both BSE & NSE with the listing date fixed at November 6, 2023 (Monday).
Blue Jet IPO Subscription :
On the second day of Blue Jet Healthcare’s IPO, the response was noteworthy. The overall subscription rate stood at 1.32 times. Specifically, retail investors showed a keen interest, subscribing 1.37 times, while Non-Institutional Investors (NII) portion was impressively oversubscribed at 2.84 times. However, the Qualified Institutional Buyers (QIB) portion witnessed limited interest, with only 9% of the shares being booked.
Blue Jet Healthcare IPO GMP (Grey Market Premium)
The actual price of Blue Jet healthcare will will determined on 6th of November which is the listing date. However on the Grey Market
Blue Jet Healthcare GMP was trading at a premium price of ₹34 in the grey market on Thursday Morning. The current Blue Jet Healthcare GMP is ₹10 which is much lower than before. The highest GMP was at ₹95 while the official listing will happen on 6th November.
GMP is a price at which stock traders in an unregulated market before its listing on Exchanges. GMP gives an idea about how the Investors feel about the IPO prior to its listing. A positive GMP indicates that the stock is trading at a premium and will likely list at profit on the Listing day however a negative GMP indicates that the stock is trading at a discount and will likely list at a loss on the Listing day.
More about BLUE JET HEALTHCARE PVT LTD
Blue Jet Healthcare was Established in 1968, Blue Jet Healthcare is a company deeply rooted in pharmaceuticals and healthcare ingredients. They hold the distinction of being the pioneers in India for manufacturing saccharin and its salts (popular artificial sweeteners). As they progressed, they diversified into creating contrast media intermediates essential for CT scans and MRIs.
Blue Jet Healthcare primarily focuses on three key product categories: contrast media intermediates, high-intensity sweeteners, and pharmaceutical intermediates and active pharmaceutical ingredients.
They provide invaluable services such as developing advanced pharmaceutical processes, ensuring global regulatory compliance, and fostering collaborations for the production of cutting-edge pharmaceutical intermediates and active pharmaceutical ingredients.
Strength
- Between 2020 and 2022, Blue Jet played a significant role, contributing more than 75% of India’s selected contrast media intermediates’ value.
- In the year 2020, Blue Jet Healthcare introduced a groundbreaking contrast media intermediate, serving as the basis for all gadolinium-based contrast media.
- In the last three financial years, including the three months ending June 30, 2023, Blue Jet Healthcare successfully served over 400 customers across 39 different countries.
- Blue Jet Healthcare is involved in various supply agreements, ranging from one to four years. More than 70% of their sales from 2021 to June 2023 came from these agreed-upon volumes.
- Blue Jet Healthcare partnered with major clients like Colgate-Palmolive (India) Limited, Unilever, Prinova US LLC, MMAG Co etc.
